Stopgap Bill

Showing 4684 articles
Business

Robinhood Markets: A Valuation Crossroads Amid Share Price Slump

Robinhood Markets (HOOD) shares face sustained pressure, creating a stark contrast with its reported strong annual revenue of $4.2 billion and net income of $2.2 billion. As investors weigh the disconnect, a prominent fair value estimate suggests significant upside, though lofty multiples and regulatory clouds loom.

Business

Merck Navigates Mixed Q4 2025 with Oncology Strength Offsetting Vaccine Slump, Sets Cautious 2026 Outlook

Merck & Co. reported a 5% rise in Q4 2025 revenue to $16.4 billion, powered by its blockbuster cancer drug Keytruda and animal health division. However, a steep 35% drop in Gardasil sales, attributed to weakened demand in Asia, highlighted regional vulnerabilities. The pharmaceutical giant issued initial 2026 guidance projecting modest growth while absorbing a significant one-time charge from its recent Cidara Therapeutics acquisition.

Business

Waymo Secures $16B at $126B Valuation, Navigating Growth Amid Safety Scrutiny

The autonomous vehicle leader Waymo has catapulted to a $126 billion valuation after a massive $16 billion funding round, marking its transition from a moonshot project to a commercial-scale operation. Yet, this financial milestone arrives as the company faces intensified regulatory pressure following a series of incidents involving its robotaxis and school buses.